Captrust Financial Advisors Purchases 4,683 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR)
Captrust Financial Advisors increased its stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) by 29.6% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 20,503 shares of the company’s stock after buying an additional 4,683 shares during the quarter. Captrust Financial Advisors’ holdings in Vir Biotechnology were worth $150,000 as of its most […]
